(Q42486962)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503684%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

title

FOXA1 is an independent prognostic marker for ER-positive breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503684%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503684%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Harikrishna Nakshatri

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503684%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Rohit K Jain

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503684%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Samuel Leung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503684%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jennifer Choo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503684%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Torsten Nielsen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503684%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

David Huntsman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503684%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sunil Badve

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503684%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

English

0 references

publication date

19 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503684%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

29 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503684%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503684%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503684%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

page(s)

881-890

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21503684%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10549-011-1482-6

29 January 2020

exact match

0 references

cites work

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Multiple hepatocyte-enriched nuclear factors function in the regulation of transthyretin and alpha 1-antitrypsin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

FOXA1 is a key determinant of estrogen receptor function and endocrine response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Estrogen receptor target gene: an evolving concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Predicting the clinical status of human breast cancer by using gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

FOXA1 as a therapeutic target for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Relationship between tumor location and relapse in 6,781 women with early invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Assessment of interlaboratory variation in the immunohistochemical determination of estrogen receptor status using a breast cancer tissue microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

FoxA1 as a lineage-specific oncogene in luminal type breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

NF-kappaB represses E-cadherin expression and enhances epithelial to mesenchymal transition of mammary epithelial cells: potential involvement of ZEB-1 and ZEB-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1482-6